Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score:: an observational study

被引:110
作者
Morgenthaler, NG
Struck, J
Christ-Crain, M
Bergmann, A
Müller, B
机构
[1] Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland
[2] BRAHMS AG, Ctr Biotechnol, Dept Res, Hennigsdorf, Germany
关键词
biomarkers; diagnosis; sepsis; therapy monitoring;
D O I
10.1186/cc3015
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction Additional biomarkers in sepsis are needed to tackle the challenges of determining prognosis and optimizing selection of high-risk patients for application of therapy. In the present study, conducted in a cohort of medical intensive care unit patients, our aim was to compare the prognostic value of mid-regional pro- atrial natriuretic peptide (ANP) levels with those of other biomarkers and physiological scores. Methods Blood samples obtained in a prospective observational study conducted in 101 consecutive critically ill patients admitted to the intensive care unit were analyzed. The prognostic value of pro- ANP levels was compared with that of the Acute Physiology and Chronic Health Evaluation (APACHE) II score and with those of various biomarkers ( i.e. C-reactive protein, IL-6 and procalcitonin). Mid-regional pro- ANP was detected in EDTA plasma from all patients using a new sandwich immunoassay. Results On admission, 53 patients had sepsis, severe sepsis, or septic shock, and 68 had systemic inflammatory response syndrome. The median pro- ANP value in the survivors was 194 pmol/l ( range 20 - 2000 pmol/l), which was significantly lower than in the nonsurvivors ( median 853.0 pmol/l, range 100 - 2000 pmol/l; P < 0.001). On the day of admission, pro- ANP levels, but not levels of other biomarkers, were significantly higher in surviving than in nonsurviving sepsis patients ( P = 0.001). In a receiver operating characteristic curve analysis for the survival of patients with sepsis, the area under the curve (AUC) for pro- ANP was 0.88, which was significantly greater than the AUCs for procalcitonin and C-reactive protein, and similar to the AUC for the APACHE II score. Conclusion Pro-ANP appears to be a valuable tool for individual risk assessment in sepsis patients and for stratification of high-risk patients in future intervention trials. Further studies are needed to validate our results.
引用
收藏
页码:R37 / R45
页数:9
相关论文
共 47 条
[1]   CIRCULATING CONCENTRATIONS AND PHYSIOLOGICAL-ROLE OF ATRIAL-NATRIURETIC-PEPTIDE DURING ENDOTOXIC-SHOCK IN THE RAT [J].
AIURA, K ;
UEDA, M ;
ENDO, M ;
KITAJIMA, M .
CRITICAL CARE MEDICINE, 1995, 23 (11) :1898-1906
[2]   Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[3]   Clinical review 167 -: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis:: A journey from calcitonin back to its precursors [J].
Becker, KL ;
Nylén, ES ;
White, JC ;
Müller, B ;
Snider, RH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (04) :1512-1525
[4]   Differential secretion of atrial and brain natriuretic peptide in critically ill patients [J].
Berendes, E ;
Van Aken, H ;
Raufhake, C ;
Schmidt, C ;
Assmann, G ;
Walter, M .
ANESTHESIA AND ANALGESIA, 2001, 93 (03) :676-682
[5]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[6]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[7]   Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice [J].
Buckley, MG ;
Marcus, NJ ;
Yacoub, MH .
CLINICAL SCIENCE, 1999, 97 (06) :689-695
[8]   Plasma atrial natriuretic peptide (ANP) fragments proANP (1-30) and proANP (31-67) measurements in chronic heart failure: a useful index for heart trasplantation? [J].
Cappellin, E ;
Gatti, R ;
Spinella, P ;
De Palo, CB ;
Woloszczuk, W ;
Maragno, I ;
De Palo, EF .
CLINICA CHIMICA ACTA, 2001, 310 (01) :49-52
[9]   Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections:: cluster-randomised, single-blinded intervention trial [J].
Christ-Crain, M ;
Jaccard-Stolz, D ;
Bingisser, R ;
Gencay, MM ;
Huber, PR ;
Tamm, M ;
Müller, B .
LANCET, 2004, 363 (9409) :600-607
[10]   Marked elevations in N-terminal brain natriuretic peptide levels in septic shock [J].
Chua, G ;
Lee, KH .
CRITICAL CARE, 2004, 8 (04) :R248-R250